LYTIR

Company · ANIK

Anika Therapeutics Inc.

Name as listed on its exchange; filed with the SEC as Anika Therapeutics, Inc.

Nasdaq's symbol directory lists ANIK on Nasdaq as “Anika Therapeutics Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($41K); 2 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Gary P. Fischetti bought on 2 days latest Aug 4, 2026 bought $41K
Every trade (2)
  1. BUYGary P. Fischetti bought Aug 4, 2026 1,000 shares filing $20K
  2. BUYGary P. Fischetti bought Aug 3, 2026 1,000 shares filing $21K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Vanguard Capital Management filed Jul 31, 2026 Schedule 13G/A passive 659,216 shares filing 4.95%
  2. BlackRock Portfolio Management LLC filed Jul 17, 2026 Schedule 13G/A passive 544,710 shares filing 4.1%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 6, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.